NICE Guidance on Momelotinib for the treatment of Myelofibrosis

We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has recently released guidance recommending momelotinib as an option within the NHS for treating myelofibrosis-related splenomegaly (enlarged spleen) or symptoms in adults with intermediate-2 or high-risk myelofibrosis (MF) with moderate to severe anaemia, who have not had a JAK inhibitor…

Fundraising Team Christmas message 2023

The MPN Voice Fundraising Team would like to say a huge THANK YOU to everyone who took part in fundraising events and made donations in 2023, and to all your amazing supporters for their generosity.  There have been many inspirational fundraising events all with very moving stories behind the motivation to raise incredible funds for…

Christmas message 2023

Hello everyone It’s that time of year again for the round-up of the MPN Voice year, and once again it has been an amazing and very busy year. Forums, in-person and virtual online – the in-person forum calendar was full this year, with 7 forums in Galway, Nottingham, Inverness, Llandudno, Newcastle-upon-Tyne, Leeds and Edinburgh, all…